Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Recipes to spice up intestine well being: 2 scrumptious, science-backed dishes
Dr. Linda Shiue is a practicing doctor and cook with a passion for the intersection of these two areas. "We use spices for...